Léim chuig an ábhar
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
CASTA
  • Statin Cost-Effectiveness in t...
  • Luaigh é seo
  • Seol mar théacs é seo
  • Seol é seo mar r-phost
  • Priontáil
  • Easpórtáil taifead
    • Easpórtáil chuig RefWorks
    • Easpórtáil chuig EndNoteWeb
    • Easpórtáil chuig EndNote
  • Buan-nasc
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels

Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Mihaylova, B, Briggs, A, Hlatky, M, Armitage, J, Parish, S, Gray, A, Collins, R, Study, HP
Formáid: Journal article
Foilsithe / Cruthaithe: 2009
  • Stoc
  • Cur síos
  • Míreanna comhchosúla
  • Amharc foirne
Cur síos
Achoimre:

Míreanna comhchosúla

  • Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
    de réir: Mihaylova, B, et al.
    Foilsithe / Cruthaithe: (2005)
  • Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
    de réir: Mihaylova, B, et al.
    Foilsithe / Cruthaithe: (2005)
  • Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
    de réir: Mihaylova, B, et al.
    Foilsithe / Cruthaithe: (2006)
  • Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
    de réir: Mihaylova, B, et al.
    Foilsithe / Cruthaithe: (2024)
  • The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
    de réir: Kent, S, et al.
    Foilsithe / Cruthaithe: (2016)

Roghanna cuardaigh

  • Stair cuardach
  • Cuardach Casta

Aimsigh tuilleadh

  • Brabhsáil an chatalóg
  • Brabhsáil in ord aibítre
  • Breathnaigh ar chainéil
  • Áirithintí cúrsa
  • Míreanna nua

Cabhair uait?

  • Leideanna cuardaigh
  • Cuir ceist ar leabharlannaí
  • CCanna